Ambey Laboratories IPO vs Visaman Global Sales IPO
Comparison between Ambey Laboratories IPO and Visaman Global Sales IPO.
IPO Details
Ambey Laboratories IPO is a SME Fixed Price IPO proposed to list at NSE SME while Visaman Global Sales IPO is a SME Fixed Price proposed to list at NSE SME.
The total issue size of Ambey Laboratories IPO is up to ₹42.43 Cr whereas the issue size of the Visaman Global Sales IPO is up to ₹15.22 Cr. The final issue price of Ambey Laboratories IPO is ₹68.00 per share and of Visaman Global Sales IPO is ₹43.00 per share.
Ambey Laboratories IPO opens on Jul 04, 2024, while Visaman Global Sales IPO opens on Jun 24, 2024. The closing date of Ambey Laboratories IPO and Visaman Global Sales IPO is Jul 08, 2024, and Jun 26, 2024, respectively.
In the Ambey Laboratories IPO Retail Individual Investors (RII) are offered 21,84,000 shares while in Visaman Global Sales IPO retail investors are offered 21,84,000 shares. Qualified Institutional Buyers (QIB) are offered 12,48,000 shares in Ambey Laboratories IPO and 0 shares in Visaman Global Sales IPO.